APA
Saintas E., Abrahams L., Ahmad G. T., Ajakaiye A. M., AlHumaidi A. S. H. A. M., Ashmore-Harris C., Clark I., Dura U. K., Fixmer C. N., Ike-Morris C., Mato Prado M., Mccullough D., Mishra S., Schöler K. M. U., Timur H., Williamson M. D. C., Alatsatianos M., Bahsoun B., Blackburn E., Hogwood C. E., Lithgow P. E., Rowe M., Yiangou L., Rothweiler F., Cinatl J., Zehner R., Baines A. J., Garrett M. D., Gourlay C. W., Griffin D. K., Gullick W. J., Hargreaves E., Howard M. J., Lloyd D. R., Rossman J. S., Smales C. M., Tsaousis A. D., von der Haar T., Wass M. N. & Michaelis M. (20170829). Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS. : PloS one.
Chicago
Saintas Emily, Abrahams Liam, Ahmad Gulshan T, Ajakaiye Anu-Oluwa M, AlHumaidi Abdulaziz S H A M, Ashmore-Harris Candice, Clark Iain, Dura Usha K, Fixmer Carine N, Ike-Morris Chinedu, Mato Prado Mireia, Mccullough Danielle, Mishra Shishir, Schöler Katia M U, Timur Husne, Williamson Maxwell D C, Alatsatianos Markella, Bahsoun Basma, Blackburn Edith, Hogwood Catherine E, Lithgow Pamela E, Rowe Michelle, Yiangou Lyto, Rothweiler Florian, Cinatl Jindrich, Zehner Richard, Baines Anthony J, Garrett Michelle D, Gourlay Campbell W, Griffin Darren K, Gullick William J, Hargreaves Emma, Howard Mark J, Lloyd Daniel R, Rossman Jeremy S, Smales C Mark, Tsaousis Anastasios D, von der Haar Tobias, Wass Mark N and Michaelis Martin. 20170829. Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS. : PloS one.
Harvard
Saintas E., Abrahams L., Ahmad G. T., Ajakaiye A. M., AlHumaidi A. S. H. A. M., Ashmore-Harris C., Clark I., Dura U. K., Fixmer C. N., Ike-Morris C., Mato Prado M., Mccullough D., Mishra S., Schöler K. M. U., Timur H., Williamson M. D. C., Alatsatianos M., Bahsoun B., Blackburn E., Hogwood C. E., Lithgow P. E., Rowe M., Yiangou L., Rothweiler F., Cinatl J., Zehner R., Baines A. J., Garrett M. D., Gourlay C. W., Griffin D. K., Gullick W. J., Hargreaves E., Howard M. J., Lloyd D. R., Rossman J. S., Smales C. M., Tsaousis A. D., von der Haar T., Wass M. N. and Michaelis M. (20170829). Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS. : PloS one.
MLA
Saintas Emily, Abrahams Liam, Ahmad Gulshan T, Ajakaiye Anu-Oluwa M, AlHumaidi Abdulaziz S H A M, Ashmore-Harris Candice, Clark Iain, Dura Usha K, Fixmer Carine N, Ike-Morris Chinedu, Mato Prado Mireia, Mccullough Danielle, Mishra Shishir, Schöler Katia M U, Timur Husne, Williamson Maxwell D C, Alatsatianos Markella, Bahsoun Basma, Blackburn Edith, Hogwood Catherine E, Lithgow Pamela E, Rowe Michelle, Yiangou Lyto, Rothweiler Florian, Cinatl Jindrich, Zehner Richard, Baines Anthony J, Garrett Michelle D, Gourlay Campbell W, Griffin Darren K, Gullick William J, Hargreaves Emma, Howard Mark J, Lloyd Daniel R, Rossman Jeremy S, Smales C Mark, Tsaousis Anastasios D, von der Haar Tobias, Wass Mark N and Michaelis Martin. Acquired resistance to oxaliplatin is not directly associated with increased resistance to DNA damage in SK-N-ASrOXALI4000, a newly established oxaliplatin-resistant sub-line of the neuroblastoma cell line SK-N-AS. : PloS one. 20170829.